CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Training offer
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2022-23
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Liquid Biopsy and Carcinogenesis
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Non-Coding RNA and Cancer Genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Una investigadora del Cima Universidad de Navarra recibe la prestigiosa ‘ERC Starting Grant’ para desarrollar terapia génica para enfermedades renales
La Comisión Europea concede uno de los premios más competitivos de Europa, la beca ERC Starting Grant por valor de 1,5 millones de euros, a la Dra. Nerea Zabaleta del Cima Universidad de Navarra.
Esta financiación tiene como objetivo apoyar la investigación de excelencia de la nueva generación de investigadores en Europa.
September 4, 2025
El CCUN participa en un consorcio europeo que ampliará el acceso de pacientes al tratamiento con CAR-T
El proyecto EASYGEN cuenta con 8 millones de euros de financiación y busca mejorar los flujos de trabajo hospitalarios para que esta terapia celular que fortalece el sistema inmunitario frente al cáncer sea más rápida, asequible y universal
August 26, 2025
El Cima recibe 5.000 euros para investigación en cáncer infantil gracias al torneo de pádel Beatriz Ramírez
Este campeonato solidario celebra su segunda edición a favor de Niños Contra el Cáncer, programa social de la Clínica Universidad de Navarra
August 22, 2025
Stellate cells are also essential for the proper functioning of the liver
Dr. Josepmaria Argemí has published in Nature that the role of these cells goes beyond promoting liver fibrosis when they are activated in response to chronic damage.
August 4, 2025
A novel therapy eradicates triple negative breast cancer recurrence in preclinical models
The results achieved by a group from the Spanish research center Cima Universidad de Navarra show that ENPP1 blockade increases the efficacy of radiotherapy abrogating the primary tumor and impairing metastases
July 28, 2025
Dr. José Luis Lanciego, appointed president of the European Brain Foundation
The aim of the EBF is to promote the funding of scientific projects aimed at reducing the social, health, and economic impact of brain diseases, which affect around a third of the European population.
July 22, 2025
